CN102844032A - 治疗呼吸道病症或疾病的化合物 - Google Patents

治疗呼吸道病症或疾病的化合物 Download PDF

Info

Publication number
CN102844032A
CN102844032A CN2011800192025A CN201180019202A CN102844032A CN 102844032 A CN102844032 A CN 102844032A CN 2011800192025 A CN2011800192025 A CN 2011800192025A CN 201180019202 A CN201180019202 A CN 201180019202A CN 102844032 A CN102844032 A CN 102844032A
Authority
CN
China
Prior art keywords
ethyoxyl
piperidin
benzo
methyl
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2011800192025A
Other languages
English (en)
Chinese (zh)
Inventor
J·N·兰伯特
J·瑞恩
J·M·威尔逊
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biota Scientific Management Pty Ltd
Original Assignee
Biota Scientific Management Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2010901601A external-priority patent/AU2010901601A0/en
Application filed by Biota Scientific Management Pty Ltd filed Critical Biota Scientific Management Pty Ltd
Priority to CN201510982692.9A priority Critical patent/CN105560245A/zh
Publication of CN102844032A publication Critical patent/CN102844032A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CN2011800192025A 2010-04-15 2011-04-14 治疗呼吸道病症或疾病的化合物 Pending CN102844032A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510982692.9A CN105560245A (zh) 2010-04-15 2011-04-14 治疗呼吸道病症或疾病的化合物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2010901601 2010-04-15
AU2010901601A AU2010901601A0 (en) 2010-04-15 Compound for the treatment of respiratory condition or disease
PCT/AU2011/000434 WO2011127538A1 (en) 2010-04-15 2011-04-14 Compound for treatment of respiratory condition or disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CN201510982692.9A Division CN105560245A (zh) 2010-04-15 2011-04-14 治疗呼吸道病症或疾病的化合物

Publications (1)

Publication Number Publication Date
CN102844032A true CN102844032A (zh) 2012-12-26

Family

ID=44788654

Family Applications (2)

Application Number Title Priority Date Filing Date
CN2011800192025A Pending CN102844032A (zh) 2010-04-15 2011-04-14 治疗呼吸道病症或疾病的化合物
CN201510982692.9A Pending CN105560245A (zh) 2010-04-15 2011-04-14 治疗呼吸道病症或疾病的化合物

Family Applications After (1)

Application Number Title Priority Date Filing Date
CN201510982692.9A Pending CN105560245A (zh) 2010-04-15 2011-04-14 治疗呼吸道病症或疾病的化合物

Country Status (16)

Country Link
US (1) US20110257192A1 (enExample)
EP (1) EP2558097B1 (enExample)
JP (1) JP6148618B2 (enExample)
KR (1) KR20130106267A (enExample)
CN (2) CN102844032A (enExample)
AU (1) AU2011241478B2 (enExample)
BR (1) BR112012026244A2 (enExample)
CA (1) CA2796207A1 (enExample)
EA (1) EA025224B1 (enExample)
ES (1) ES2647223T3 (enExample)
IL (1) IL222244A0 (enExample)
MX (1) MX2012011938A (enExample)
NZ (1) NZ603040A (enExample)
SG (2) SG184430A1 (enExample)
WO (1) WO2011127538A1 (enExample)
ZA (1) ZA201207696B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL266301B2 (en) 2013-04-12 2023-03-01 Obschestvo S Ogranichennoi Otvetstvennostiyu Pharmenterprises History of glutarimide, their use, pharmaceutical preparation based on them and methods for producing history of glutarimide
US9802926B2 (en) * 2014-06-20 2017-10-31 Aviragen Therapeutics, Inc. Anhydrous crystalline free base form of 6-{2-[1 -(6-methyl-3-pyridazinyl)-4-piperidinyl]ethoxy}-3-ethoxy-1,2-benzisoxazole
WO2024192149A2 (en) * 2023-03-13 2024-09-19 Altesa BioSciences, Inc. Method of treating enterovirus in chronic obstructive pulmonary disease patients

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002050045A1 (en) * 2000-12-18 2002-06-27 Biota Scientific Management Pty Ltd Antiviral agents
WO2009143571A1 (en) * 2008-05-27 2009-12-03 Biota Scientific Management Pty Ltd Antiviral salts
WO2010009288A1 (en) * 2008-07-17 2010-01-21 Schering Corporation Compositions and uses of antiviral active pharmaceutical agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003215246A1 (en) * 2002-02-14 2003-09-04 Viropharma Incorporated Methods of reducing rhinovirus contagion and related compositions
ATE399549T1 (de) * 2003-02-21 2008-07-15 Apodemus Ab Behandlung von durch das ljungan-virus ausgelösten erkrankungen durch verwendung von pleconaril
US9308199B2 (en) * 2004-04-29 2016-04-12 Honeywell International Inc. Medicament formulations
US20060069124A1 (en) * 2004-09-07 2006-03-30 Rao P S Use of MDL-100,907 for treatment of allergic and eosinophil mediated diseases
AR057623A1 (es) * 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002050045A1 (en) * 2000-12-18 2002-06-27 Biota Scientific Management Pty Ltd Antiviral agents
WO2009143571A1 (en) * 2008-05-27 2009-12-03 Biota Scientific Management Pty Ltd Antiviral salts
WO2010009288A1 (en) * 2008-07-17 2010-01-21 Schering Corporation Compositions and uses of antiviral active pharmaceutical agents

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JAMES E. GERN1等: "Association of Rhinovirus Infections with Asthma", 《CLINICAL MICROBIOLOGY REVIEWS》 *
P.MALLIA等: "Exacerbations of Asthma and Chronic Obstructive Pulmonary Disease(COPD): Focus on Virus Induced Exacerbations", 《CURRENT PHARMACEUTICAL DESIGN》 *

Also Published As

Publication number Publication date
KR20130106267A (ko) 2013-09-27
BR112012026244A2 (pt) 2016-07-12
EP2558097A1 (en) 2013-02-20
EA025224B1 (ru) 2016-12-30
CA2796207A1 (en) 2011-10-20
EA201201416A1 (ru) 2013-03-29
NZ603040A (en) 2015-03-27
IL222244A0 (en) 2012-12-31
EP2558097A4 (en) 2013-09-11
AU2011241478B2 (en) 2016-12-01
AU2011241478A1 (en) 2012-11-01
ES2647223T3 (es) 2017-12-20
WO2011127538A1 (en) 2011-10-20
EP2558097B1 (en) 2017-10-25
MX2012011938A (es) 2013-01-28
CN105560245A (zh) 2016-05-11
SG184430A1 (en) 2012-11-29
JP2013523844A (ja) 2013-06-17
ZA201207696B (en) 2014-03-26
US20110257192A1 (en) 2011-10-20
SG10201502391WA (en) 2015-05-28
JP6148618B2 (ja) 2017-06-14

Similar Documents

Publication Publication Date Title
US11975005B2 (en) Treatment of respiratory diseases
US20240009220A1 (en) Methods for treatment of viral infections
US20240316082A1 (en) Medicament for prevention or treatment of rhinovirus infection
CN117695284B (zh) 冠状病毒感染的治疗
AU2017325010A1 (en) Mast cell stabilizers for treatment of hypercytokinemia and viral infection
CN105517631A (zh) 左西替利嗪和孟鲁司特在治疗创伤性损伤中的用途
CN102844032A (zh) 治疗呼吸道病症或疾病的化合物
US11433080B2 (en) Antiviral treatment
CN116744934A (zh) 用于治疗病毒性呼吸疾病的吸入性他汀类药物
US12083135B2 (en) Use of a nitrogen-containing bisphosphonate in combination with a glucocorticoid in preventing or treating viral pneumonia
CN117618436A (zh) 一种稠环嘧啶类化合物的用途
US20220304959A1 (en) Treatment of long haulers syndrome with niclosamide
CN118317775A (zh) 治疗冠状病毒感染的新联用药物、药物组合物及其用途
CN116782905A (zh) 治疗COVID-19和预防SARS-CoV-2感染的配制品和方法
HK40058742B (zh) 呼吸性疾病的治疗

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20121226